These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 37293562)

  • 41. Although leukoplakia responds to some treatments relapses and adverse effects are common.
    Lele S
    Evid Based Dent; 2005; 6(1):15-6. PubMed ID: 15789045
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Tissue biomarkers for predicting the risk of oral cancer in patients diagnosed with oral leukoplakia: A systematic review.
    Monteiro L; Mello FW; Warnakulasuriya S
    Oral Dis; 2021 Nov; 27(8):1977-1992. PubMed ID: 33290585
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Chemoprevention strategies in lung carcinogenesis.
    Lippman SM; Benner SE; Hong WK
    Chest; 1993 Jan; 103(1 Suppl):15S-19S. PubMed ID: 8416769
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Quantitative Immunoexpression of EGFR in Oral Potentially Malignant Disorders: Oral Leukoplakia and Oral Submucous Fibrosis.
    Jyothi Meka N; Ugrappa S; Velpula N; Kumar S; Naik Maloth K; Kodangal S; Ch L; Goyal S
    J Dent Res Dent Clin Dent Prospects; 2015; 9(3):166-74. PubMed ID: 26697149
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Development of chemopreventive agents for lung and upper aerodigestive tract cancers.
    Kelloff GJ; Boone CW; Steele VK; Perloff M; Crowell J; Doody LA
    J Cell Biochem Suppl; 1993; 17F():2-17. PubMed ID: 8412195
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Chemoprevention of oral cancer in animal models, and effect on leukoplakias in human patients with ZengShengPing, a mixture of medicinal herbs.
    Sun Z; Guan X; Li N; Liu X; Chen X
    Oral Oncol; 2010 Feb; 46(2):105-10. PubMed ID: 20022553
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Curcumin and metformin-mediated chemoprevention of oral cancer is associated with inhibition of cancer stem cells.
    Siddappa G; Kulsum S; Ravindra DR; Kumar VV; Raju N; Raghavan N; Sudheendra HV; Sharma A; Sunny SP; Jacob T; Kuruvilla BT; Benny M; Antony B; Seshadri M; Lakshminarayan P; Hicks W; Suresh A; Kuriakose MA
    Mol Carcinog; 2017 Nov; 56(11):2446-2460. PubMed ID: 28618017
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Evaluation of the clinical and histological effectiveness of isotretinoin in the therapy of oral leukoplakia: ten years of experience: is management still up to date and effective?
    Scardina GA; Carini F; Maresi E; Valenza V; Messina P
    Methods Find Exp Clin Pharmacol; 2006 Mar; 28(2):115-9. PubMed ID: 16636722
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Risk biomarkers and current strategies for cancer chemoprevention.
    Kelloff GJ; Boone CW; Crowell JA; Nayfield SG; Hawk E; Malone WF; Steele VE; Lubet RA; Sigman CC
    J Cell Biochem Suppl; 1996; 25():1-14. PubMed ID: 9027592
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Black tea (Camellia sinensis) as a chemopreventive agent in oral precancerous lesions.
    Halder A; Raychowdhury R; Ghosh A; De M
    J Environ Pathol Toxicol Oncol; 2005; 24(2):141-4. PubMed ID: 15831086
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Some perspectives on dietary inhibition of carcinogenesis: studies with curcumin and tea.
    Conney AH; Lou YR; Xie JG; Osawa T; Newmark HL; Liu Y; Chang RL; Huang MT
    Proc Soc Exp Biol Med; 1997 Nov; 216(2):234-45. PubMed ID: 9349692
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Novel approaches to chemoprevention of skin cancer.
    Bickers DR; Athar M
    J Dermatol; 2000 Nov; 27(11):691-5. PubMed ID: 11138532
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Metformin and oral cancer: In reply with emphasis on an emerging role of an old drug in oral cancer chemoprevention.
    Zhu L; Deng Y; Ji T; Zhou H; Liu W
    Oral Oncol; 2022 Dec; 135():106196. PubMed ID: 36257182
    [No Abstract]   [Full Text] [Related]  

  • 54. Malignant transformation of Taiwanese patients with oral leukoplakia: A nationwide population-based retrospective cohort study.
    Wang TY; Chiu YW; Chen YT; Wang YH; Yu HC; Yu CH; Chang YC
    J Formos Med Assoc; 2018 May; 117(5):374-380. PubMed ID: 29428194
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Accumulation of p53 protein and retinoic acid receptor beta in retinoid chemoprevention.
    Shin DM; Xu XC; Lippman SM; Lee JJ; Lee JS; Batsakis JG; Ro JY; Martin JW; Hittelman WN; Lotan R; Hong WK
    Clin Cancer Res; 1997 Jun; 3(6):875-80. PubMed ID: 9815762
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Not significant but important.
    Mulshine JL; Ondrey FG
    Cancer Prev Res (Phila); 2013 May; 6(5):371-4. PubMed ID: 23639860
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Photodynamic therapy combined with laser drilling successfully prevents the recurrence of refractory oral proliferative verrucous leukoplakia.
    Wang F; Shi Y; Dong Y; Liu T; Dan H; Wang J; Zeng X
    Photodiagnosis Photodyn Ther; 2021 Dec; 36():102564. PubMed ID: 34610431
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Use of antioxidant supplements in the treatment of human oral leukoplakia.
    Kaugars GE; Silverman S; Lovas JG; Thompson JS; Brandt RB; Singh VN
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 1996 Jan; 81(1):5-14. PubMed ID: 8850475
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Chemoprevention of cancer].
    Ujházy V
    Bratisl Lek Listy; 1996 Jan; 97(1):19-23. PubMed ID: 8689296
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Nomogram for risk prediction of malignant transformation in oral leukoplakia patients using combined biomarkers.
    Zhang X; Kim KY; Zheng Z; Bazarsad S; Kim J
    Oral Oncol; 2017 Sep; 72():132-139. PubMed ID: 28797449
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.